Evaluating Treatment Options for Opiate Use Disorder: A Meta-Analysis of Buprenorphine-Naloxone and Extended-Release Naltrexone
Bassam H Awaji, Sobhia N Abanmi, Leen Alhodathi, Mohammed Alrehaili et autres
Opioid use disorder (OUD) is a chronic, relapsing condition with significant health and social consequences. Buprenorphine-naloxone (BUP-NX) and extended-release naltrexone (XR-NTX) are two primary medications used for OUD treatment. A systematic review and meta-analysis were conducted. PubMed, Embase, and Cochrane databases were …
sa, is, cn, bd, qa, in (code pays fourni par la source)